Related Stories GLP-1 weight-loss drugs may also reduce binge eating Semaglutide fuels rapid growth in US GLP-1RA use as payments rise Study links GLP-1 treatment to fewer alcohol drinking days In comparison to composite control, GLP-1RA use exhibited a decreased risk of 34 outcomes, including pneumonia, respiratory failure, alcohol use disorders, COPD, and suicidal ideation, and an increased risk of 17 outcomes, including abdominal pain, GERD, nephrolithiasis, and sleep disturbances
Drugs 79 , 15991606 (2019)
Amazon Elements thoroughly tests every batch of product for quality and safety--see below for detailed information about ingredient origins
By integrating metabolomics data with clinical trial outcomes, researchers can more accurately assess the real-world impact of Chinese medicine on depression treatment